Skip to content

Pelvic Alignment Level (PAL) Instrument Evaluation

A Prospective Clinical Evaluation of Acetabular Cup Placement in Total Hip Replacements Utilizing a Pelvic Alignment Level (PAL) Instrument

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01312428
Acronym
PAL
Enrollment
7
Registered
2011-03-10
Start date
2011-02-28
Completion date
2012-04-30
Last updated
2017-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arthroplasty, Replacement, Hip

Brief summary

The study is conducted to evaluate the performance of the Pelvic Alignment Level (PAL) instrument in achieving desired acetabular position, desired leg length and offset after Total Hip Replacement (THR) reconstruction.

Detailed description

Total hip replacement (THR) has been a sucessful treatment for cases of degenerative joint diseases. However, post operative complications such as dislocations, osteolysis, component wear and migration are still a concern. It has been noted in the scientific literature that precise acetabular cup position helps reduce such post operative complications. The Pelvic Alignment Level (PAL) offers this solution by assessing pelvic motion and optimizing implant position without the need for intra-operative fluoroscopy or a large capital expenditure. The focus of this study is to evaluate the clinical outcomes (acetabular cup placement, femoral offset, and leg length) of using the PAL instrument to those without using PAL instrument during total hip replacement. This will be a prospective, post market, randomized multi-center clinical study.

Interventions

DEVICEPelvic Alignment Level (PAL) Instrument

Pelvic Alignment Level Instrument Used

DEVICENo Pelvic Alignment Level (PAL) Instrument

No Pelvic Alignment Level Instrument Used

Sponsors

Stryker Orthopaedics
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient has signed an IRB approved, evaluation specific Informed Patient Consent Form. * Patient is a male or non-pregnant female age 18 years or older at time of enrollment. * Patient clinically qualifies for total hip arthroplastic surgery, based on physical examination and medical history. * Patient must have a diagnosis of: osteoarthritis, traumatic arthritis, avascular necrosis, slipped capital epiphysis, pelvic fracture, failed fracture fixation or rheumatoid arthritis.

Exclusion criteria

* Patient's anatomy precludes a cup placement of 45° inclination and 20° anteversion. * Patient has an active infection within the affected hip joint. * Patient is a prisoner. * Patient has plans to relocate to another geographic area before the completion of the evaluation.

Design outcomes

Primary

MeasureTime frame
To Evaluate the Surgical Accuracy in Placing Acetabular Components at a Target of 45° Inclination and 20° Anteversion While Using the PAL Compared to Surgeries Without Using the PAL Instrument.6 week follow-up

Secondary

MeasureTime frame
To Evaluate the Surgical Success of Achieving Preoperative Targets for Leg Length and Femoral Offset, or be Able to Document Changes to Pre-operative Leg Length and Offset, Using the PAL Compared to Surgeries Without Using the PAL Instrument.6 week follow-up

Countries

United States

Participant flow

Participants by arm

ArmCount
PAL (Pelvic Alignment Level)
The cases randomized into the PAL group will have total hip replacement surgery performed utilizing the PAL instrument. Pelvic Alignment Level (PAL) Instrument: Total hip replacement surgery will be performed utilizing the PAL Instrument.
3
No PAL (No Pelvic Alignment Level)
The cases randomized into the no PAL group will have total hip replacement surgery performed without the use of the PAL instrument. This group will serve as the control group. Total Hip Replacement: Total hip replacement surgery will be performed without utilizing the PAL Instrument.
4
Total7

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyStudy Termination34

Baseline characteristics

CharacteristicPAL (Pelvic Alignment Level)No PAL (No Pelvic Alignment Level)Total
Age, Continuous65 years
STANDARD_DEVIATION 12.9
65.9 years
STANDARD_DEVIATION 4.1
65.5 years
STANDARD_DEVIATION 8
Sex: Female, Male
Female
2 Participants1 Participants3 Participants
Sex: Female, Male
Male
1 Participants3 Participants4 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 30 / 4
serious
Total, serious adverse events
1 / 30 / 4

Outcome results

Primary

To Evaluate the Surgical Accuracy in Placing Acetabular Components at a Target of 45° Inclination and 20° Anteversion While Using the PAL Compared to Surgeries Without Using the PAL Instrument.

Time frame: 6 week follow-up

Population: The study was terminated early, therefore, primary or secondary measures were not assessed.

Secondary

To Evaluate the Surgical Success of Achieving Preoperative Targets for Leg Length and Femoral Offset, or be Able to Document Changes to Pre-operative Leg Length and Offset, Using the PAL Compared to Surgeries Without Using the PAL Instrument.

Time frame: 6 week follow-up

Population: The study was terminated early, therefore, primary or secondary measures were not assessed.

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026